Cell-Based Assays market is projected to grow at a CAGR of 8.7% by 2034: Visiongain
05. Januar 2024 11:02 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Cell-Based Assays Market Report 2024-2034: Forecasts by Product (Instruments (Microplates, Microplate Reader, Liquid Handling System, Incubator,...
Stem Cell Therapy Contract Manufacturing market is projected to grow at a CAGR of 12.4% by 2033: Visiongain
13. September 2023 09:09 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Stem Cell Therapy Contract Manufacturing Market Report 2023-2033: Forecasts by Scale of Operation (Commercial, Clinical, Preclinical), by Size of...
Bionic Devices market is projected to grow at a CAGR of 9.5% by 2033: Visiongain
25. August 2023 10:54 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Bionic Devices Market Report 2023-2033: Forecasts by Fixation (Implantable Bionics, External Bionics), by Type (Heart Bionics, Neural Bionics, Cochlear...
Next Generation Sequencing Market is projected to grow at a CAGR of 21.1% by 2033: Visiongain
28. Juli 2023 11:10 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Next Generation Sequencing Market Report 2023-2033: Forecasts by Type (Consumables, Bioinformatics, Sequencing Services, Pre-sequencing Services,...
Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion in 2032: Visiongain Research Inc
14. April 2022 10:00 ET
|
Visiongain Ltd
Visiongain has launched a new report on the Global Pharmaceutical Contract Manufacturing Market Forecast 2022-2032: - Market Segment by Services {Pharmaceutical Manufacturing Services (Pharmaceutical...
Global non-alcoholic fatty liver disease & NASH market is projected to reach at a market value of US$62.06 Billion by 2031: Visiongain Research Inc
12. April 2022 10:35 ET
|
Visiongain Ltd
Global Non-alcoholic Fatty Liver Disease & NASH Market Forecast 2021-2031: - By Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity, Other Disease Causes) By...
Cold Laser Therapy Market Report Up to 2031: Visiongain Research Inc
24. Februar 2022 10:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Cold Laser Therapy Market Report 2021-2031: Forecasts by Product (Instruments, and Accessories), by Application (Orthopedics, Dermatology, Dentistry,...
Tissue Engineering Market Research Report Up to 2031: Visiongain Research Inc
14. Februar 2022 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Tissue Engineering Market Report 2021-2031: Forecasts by Application (Cord Blood & Cell Banking, Cancer, GI & Gynaecology, Dental, Orthopaedics,...
Viral Inactivation Market Research Report Up to 2031: Visiongain Research Inc
02. Februar 2022 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Viral Inactivation Market Report 2021-2031: Forecasts by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene...
Due Diligence Costs for Pharmaceutical In-Licensing Deals Topping $6 Million
29. Juni 2011 12:11 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 29, 2011) - The cost of conducting due diligence for a large or complex pharmaceutical in-licensing deal can run as high as $6 million, though the...